← Back to Search

Medication therapy management for Dementia (AMOR-KY Trial)

N/A

Waitlist Available

Research Sponsored by Daniela Moga

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 months and 6 months

Awards & highlights

AMOR-KY Trial Summary

This trial will study the effects of a medication intervention program led by pharmacists and physicians, delivered remotely via telemedicine, to patients with cognitive impairment in rural Appalachian Kentucky.

Eligible Conditions

Dementia
Mild Cognitive Impairment

AMOR-KY Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 months and 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 months and 6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in medication use

Connectivity issues

Participant satisfaction

Secondary outcome measures

Caregiver assessment

Cognitive function

Deprescribing assessments

AMOR-KY Trial Design

1Treatment groups

Experimental Treatment

Group I: Treatment optimizationExperimental Treatment1 Intervention

Participants will undergo an evaluation of all the medications taken and changes will be proposed for treatment optimization.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Medication therapy management

2016

N/A

~1030

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Northern California Institute of Research and EducationOTHER

27 Previous Clinical Trials

9,948 Total Patients Enrolled

1 Trials studying Dementia

1,500 Patients Enrolled for Dementia

Daniela MogaLead Sponsor

2 Previous Clinical Trials

140 Total Patients Enrolled

1 Trials studying Dementia

90 Patients Enrolled for Dementia

National Institute on Aging (NIA)NIH

1,671 Previous Clinical Trials

28,017,047 Total Patients Enrolled

266 Trials studying Dementia

23,625,344 Patients Enrolled for Dementia

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any opportunities to volunteer for this research endeavor?

"Affirmative. Clinicaltrials.gov contains information that this research is seeking participants, with the trial having been first posted on October 14th 2021 and recently updated on June 23rd 2022. This experiment requires 50 individuals from 1 centre to be enrolled into it."

Answered by AI

How many participants have been incorporated into this clinical trial?

"Affirmative, the clinicaltrials.gov website indicates that this trial is still recruiting enrollees. The study was initially posted on October 14th 2021 and amended lastly on June 23rd 2022 across a single medical centre with 50 participants being sought after in total."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Assessment of Medication Optimization in Rural Kentucky Appalachian Patients With Mild Cognitive Impairment or Dementia

Daniela Moga 2021. "Assessment of Medication Optimization in Rural Kentucky Appalachian Patients With Mild Cognitive Impairment or Dementia". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05078437.